Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Perspective Therapeutics, Inc. (CATX : AMEX)

• Company Description    Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which provide advanced treatment applications for cancers. The Company is the sole producer of Cesium-131 brachytherapy seeds. Perspective Therapeutics Inc., formerly known as Isoray Inc., is based in RICHLAND, Wash. Number of Employees: 166

• Price / Volume Information    Yesterday's Closing Price: $1.61 Daily Weekly Monthly 20 Day Moving Average: 1,697,905 shares Shares Outstanding: 114.15 (millions) Market Capitalization: $183.78 (millions) Beta: 1.84 52 Week High: $6.16 52 Week Low: $1.58 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -35.60% -34.92% 12 Week -46.15% -47.47% Year To Date -41.45% -26.59%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2401 ELLIOTT AVENUE SUITE 320 - SEATTLE,WA 98121 USA ph: 206-676-0900 fax: 509-267-3670 ir@perspectivetherapeutics.com http://www.perspectivetherapeutics.com

• General Corporate Information    Officers Johan Thijs Spoor - Chief Executive Officer and Director Lori A. Woods - Chairperson Joel Sendek - Chief Financial Officer Jonathan Hunt - Chief Accounting Officer Heidi Henson - Director Peer Information Perspective Therapeutics, Inc. (GSAC) Perspective Therapeutics, Inc. (CASIF) Perspective Therapeutics, Inc. (ALCD.) Perspective Therapeutics, Inc. (OMNN) Perspective Therapeutics, Inc. (CGPI.) Perspective Therapeutics, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 46489V302 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/09/26 Share - Related Items Shares Outstanding: 114.15 Most Recent Split Date: 6.00 (0.10:1) Beta: 1.84 Market Capitalization: $183.78 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.26 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.98 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 10.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/09/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.57 Price/Cash Flow: - Price / Sales: 449.35 EPS Growth vs. Year Ago Period: 26.67% vs. Previous Quarter: 12.00% Sales Growth vs. Year Ago Period: -72.07% vs. Previous Quarter: 6.58% ROE 09/30/26 - - 06/30/26 - -41.92 03/31/26 - -42.33 ROA 09/30/26 - - 06/30/26 - -34.42 03/31/26 - -35.05 Current Ratio 09/30/26 - - 06/30/26 - 6.61 03/31/26 - 8.75 Quick Ratio 09/30/26 - - 06/30/26 - 6.61 03/31/26 - 8.75 Operating Margin 09/30/26 - - 06/30/26 - -28,710.03 03/31/26 - -18,194.18 Net Margin 09/30/26 - - 06/30/26 - -28,467.97 03/31/26 - -17,982.69 Pre-Tax Margin 09/30/26 - - 06/30/26 - -28,710.03 03/31/26 - -18,194.18 Book Value 09/30/26 - - 06/30/26 - 2.84 03/31/26 - 3.05 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.47 03/31/26 - 0.45

Powered by Zacks Investment Research ©